YOLFTbeta
aXichem AB

aXichem AB

AXIC-A · ST · Basic Materials / Specialty Chemicals

1.64SEK-0.03 (-1.80%)

Price History

Full chart

Market Stats

Previous Close1.67
Open1.66
Day Range1.59 – 1.66
52-Week Range1.14 – 4.00
Volume51.08K
Market Cap128.69M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.25
Dividend Yield0.00%
Beta-0.59
50-Day Avg2.51
200-Day Avg1.85

About

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.

Company Details

  • SectorBasic Materials
  • IndustrySpecialty Chemicals
  • CEOMr. Torsten Helsing
  • Employees7
  • HeadquartersSOedergatan 26, Malmö, Sweden, 211 34, Sweden
  • Websitehttps://www.axichem.com

Leadership

  • Mr. Torsten HelsingCEO & Director · b. 1957
  • Mr. Erik LagerChief Operations Officer · b. 1975
  • Ms. Gunilla SavringChief Investor Relations Officer · b. 1962
  • Mr. Lucas AltepostVP and Chief Sales & Marketing officer · b. 1967

Financials

Income Statement

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue------376.00K--0344.00K343.00K1.23M4.36M5.01M1.81M8.57M18.45M
Growth (%)------------0.29%+257.73%+255.50%+14.79%-63.87%+373.74%+115.24%
Cost of Revenue---40.00K28.47K40.34K140.00K---214.00K303.00K631.00K3.45M1.19M400.00K1.49M32.96M
Gross Profit----40.00K-28.47K-40.34K236.00K---130.00K40.00K596.00K909.00K3.82M1.41M7.08M-14.51M
Gross Margin------62.77%---37.79%11.66%48.57%20.84%76.25%77.89%82.63%-78.67%
Operating Expense---2.05M3.27M3.28M5.77M---9.80M12.48M14.11M15.98M18.36M18.73M22.91M2.42M
Operating Income-622.10K-1.42M-1.83M-2.09M-3.30M-3.32M-5.53M-7.33M-5.93M-7.18M-9.67M-12.44M-13.51M-15.07M-14.54M-17.32M-15.83M-16.93M
Operating Margin-------1471.01%----2809.88%-3627.99%-1101.30%-345.48%-290.49%-957.32%-184.68%-91.79%
EBITDA-622.10K-1.42M-1.83M-2.09M-3.23M-3.32M-5.51M-7.42M-146.00K-7.18M-8.70M-11.07M-12.01M-13.49M-12.44M-15.10M-11.55M-12.04M
EBITDA Margin-------1466.76%----2529.07%-3227.99%-978.97%-309.31%-248.39%-834.88%-134.77%-65.24%
Net Income-1.05M-1.71M-2.37M-2.36M-3.48M-3.66M-5.63M-7.42M-6.07M-7.38M-9.93M-12.44M-13.52M-15.09M-17.26M-20.81M-17.81M-17.63M
Net Income Margin-------1496.81%----2885.76%-3627.99%-1101.47%-346.01%-344.72%-1150.41%-207.85%-95.59%
R&D----------336.00K514.00K736.00K910.00K1.40M1.62M--
R&D as % of Total Revenue----------97.67%149.85%59.98%20.86%28.02%89.50%--
Interest Expense0000255.66K335.99K113.00K93.00K146.00K195.00K230.00K117.00K1.00K2.00K2.69M3.47M1.96M118.00K
Interest Expense % of Total Revenue------30.05%---66.86%34.11%0.08%0.05%53.72%191.87%22.82%0.64%

Balance Sheet

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets15.87M13.27M14.74M22.51M17.36M39.13M25.38M30.87M47.01M38.56M38.44M68.97M55.75M58.77M61.25M61.49M74.28M61.09M
Total Liabilities8.50M7.62M11.46M13.38M9.34M14.21M6.44M4.60M5.68M4.70M9.34M1.82M2.10M2.47M20.92M12.96M4.13M8.22M
Total Equity7.37M5.65M3.28M9.13M8.01M24.92M18.93M26.27M41.33M33.86M29.10M67.15M53.65M56.30M40.31M48.51M70.13M52.86M
Cash152.71K88.36K954.84K78.17K2.21M16.67M4.54M6.45M497.00K5.74M3.77M30.81M12.04M9.45M6.55M4.31M14.36M3.08M
Total Debt--2.60M2.60M-1.50M--3.72M3.73M7.43M---18.76M10.27M-4.73M
Net Debt-152.71K-88.36K1.65M2.52M-2.21M-15.17M-4.54M-6.45M3.22M-2.01M3.66M-30.81M-12.04M-9.45M12.21M5.96M-14.36M1.64M

Cash Flow

Currency: SEK2008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow7.42M-3.00M-1.13M-428.50K-4.89M-4.29M-9.01M-7.98M-5.53M-7.69M-7.46M-12.29M-11.69M-15.60M-19.10M-15.68M-11.50M-11.35M
Investing Cash Flow-12.29M-451.95K-601.97K-384.29K-978.16K-1.85M-2.77M-4.39M-5.12M-3.24M-3.67M-3.85M-7.23M-4.73M-2.61M-5.10M-6.50M-4.66M
Financing Cash Flow5.03M3.39M2.60M-63.87K8.04M20.56M-357.00K14.28M4.70M16.18M9.16M43.18M17.73M17.73M18.80M18.54M28.05M4.73M
Capital Expenditure12.29M451.95K601.97K384.29K978.16K1.85M2.77M4.39M5.09M3.24M3.67M3.82M7.23M4.73M2.61M5.10M6.50M4.66M
Free Cash Flow-4.87M-3.45M-1.73M-812.80K-5.86M-6.15M-11.78M-12.37M-10.62M-10.93M-11.14M-16.12M-18.93M-20.32M-21.71M-15.68M-11.50M-16.00M
FCF to OCF-65.70%115.07%153.20%189.68%120.02%143.19%130.67%155.03%192.11%142.20%149.26%131.09%161.86%130.32%113.66%100.00%100.00%141.03%

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013May 22, 2014Aug 28, 2014Nov 24, 2014Feb 26, 2015May 25, 2015Aug 26, 2015Nov 25, 2015Feb 25, 2016May 19, 2016Aug 25, 2016Nov 11, 2016Feb 23, 2017May 24, 2017Aug 24, 2017Nov 23, 2017Feb 27, 2018May 15, 2018Aug 29, 2018Nov 15, 2018Feb 27, 2019May 23, 2019Aug 29, 2019Nov 14, 2019Feb 27, 2020May 14, 2020Aug 21, 2020Nov 12, 2020Feb 24, 2021May 20, 2021Aug 31, 2021Nov 11, 2021Feb 17, 2022May 24, 2022Aug 25, 2022Nov 24, 2022Feb 23, 2023May 24, 2023Aug 23, 2023Nov 22, 2023Mar 5, 2024May 23, 2024Aug 27, 2024Nov 28, 2024Feb 27, 2025May 22, 2025Aug 28, 2025Nov 28, 2025Feb 26, 2026May 21, 2026Aug 28, 2026
EPS Estimate-------------------------------------------------------
EPS Actual-0.39-0.03-0.12-0.21-0.37-0.14-0.24-0.16-0.16-0.21-0.44-0.15-0.20-0.13-0.16-0.13-0.17-0.10-0.11-0.12-0.16-0.12-0.19-0.16-0.18-0.15-0.23-0.19-0.22-0.19-0.23-0.20-0.22-0.20-0.24-0.18-0.30-0.21-0.31-0.32-0.19-0.29-0.25-0.21-0.25-0.25-0.03-0.15-0.10-0.10-0.06-0.05-0.09-0.05-0.06
Surprise-------------------------------------------------------
Timing-----Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-market-----

Key Statistics & Ratios

Market Cap128.69M
Enterprise Value149.44M
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.91
Price / Book2.75
EPS-0.25
Book Value0.816
Revenue (TTM)16.27M
Gross Profit (TTM)8.28M
EBITDA-12.68M
Profit Margin-95.36%
Operating Margin-106.35%
Return on Equity-26.68%
Return on Assets-15.01%
Shares Outstanding67.73M
Shares Float47.65M
Beta-0.59
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%